| 来源类型 | Working Paper
|
| 规范类型 | 报告
|
| DOI | 10.3386/w21246
|
| 来源ID | Working Paper 21246
|
| Intellectual Property Rights and Innovation: Evidence from Health Care Markets |
| Heidi L. Williams
|
| 发表日期 | 2015-06-08
|
| 出版年 | 2015
|
| 语种 | 英语
|
| 摘要 | A long theoretical literature has analyzed optimal patent policy design, yet there is very little empirical evidence on a key parameter needed to apply these models in practice: the relationship between patent strength and research investments. I argue that the dearth of empirical evidence on this question reflects two key challenges: the difficulty of measuring specific research investments, and the fact that finding variation in patent protection is difficult. I then summarize the findings of two recent studies which have made progress in starting to overcome these empirical challenges by combining new datasets measuring biomedical research investments with novel sources of variation in the effective intellectual property protection provided to different inventions. The first study, Budish, Roin, and Williams (forthcoming), documents evidence consistent with patents affecting the rate and direction of research investments in the context of cancer drug development. The second study, Williams (2013), documents evidence that one form of intellectual property rights on the human genome had quantitatively important impacts on follow-on scientific research and commercial development. I discuss the relevance of both studies for patent policy, and discuss directions for future research. |
| 主题 | Health, Education, and Welfare
; Health
; Development and Growth
; Innovation and R&
; D
|
| URL | https://www.nber.org/papers/w21246
|
| 来源智库 | National Bureau of Economic Research (United States)
|
| 引用统计 |
|
| 资源类型 | 智库出版物
|
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/578921
|
推荐引用方式
GB/T 7714 |
Heidi L. Williams. Intellectual Property Rights and Innovation: Evidence from Health Care Markets. 2015.
|
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
